The Centre for NanoHealth

The Centre for NanoHealth - CNH (nanohealth.swan.ac.uk) is a £22Million open access R&D facility dedicated to the advancement of healthcare through the application of nanotechnology.

CNH offers a fully integrated nanotechnology and biomedical R&D environment within the purpose built 1600m2 facility.

Incorporated is a fully equipped nano-fabrication and characterisation class 1000/100 cleanroom for silicon and non-silicon based developments, a class 1000 bioclean room for tissue engineering and device functionalization, NMR, rheolology, biomolecule printing, AFM, SEM, and photonics.

The nano-facility is embedded in a category 2 biomedical suite of laboratories offering cell and molecular biology capabilities, including confocal microscopy, and high-throughput/high-content analytical systems (Amnis Imagestram & GE In Cell); microbiology, regenerative medicine and tissue engineering, and nanogenotoxicolgy.

CNH is integrated with the Institute of Life Science, through which it can offer access to a 'first into man' clinical trials unit and MRI/CT patient imaging and health informatics.

CNH offers access to >50 academic staff from the Colleges of Medicine, Engineering and Science, Health Board (NHS) clinicians, and industry. The open access facility provides a technology and innovation base for SMEs in Wales and beyond. To date CNH has initiated many collaborative projects with industry and other HEIs realising more than £15Million further investment.

The Centre is a member of several global nanohealth networks including leading The Celtic Alliance for NanoHealth (celticnano.eu), the Alliance for NanoHealth (alliancefornanohealth.org), ETP nanomedicine (etp-nanomedicine.eu) and is a founding member of the Health Science and Technologies Collaborative Innovation Centre with Soochow University and Biobay in Suzhou, China.

For further information visit www.swan.ac.uk/engineering/nanohealth/ or contact the CNH manager Dr Matt Elwin m.p.elwin@swansea.ac.uk